Posted on 1/21/2016
In a world where nearly 4 billion people lack access to basic health care, the need for mobile testing using simple methods such as a single drop of blood could have momentous impacts on care.
The level of individualized, near real-time care could become a reality in the developing world, as well as in many remote areas of the industrialized world. Anita Goel, M.D., Ph.D., a Harvard-MIT-trained physicist and physician, claims, “technologies like our Gene-RADAR® are emerging from the new field of nanobiophysics which will mobilize, personalize, and decentralize...